Aptinyx Inc. Contracts & Agreements
19 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (2)
- Human Resources (5)
- Real Estate (1)
- Uncategorized (5)
- Plan of Dissolution of Aptinyx Inc (Filed With SEC on May 5, 2023)
- Description of Registrants Securities (Filed With SEC on March 30, 2023)
- Description of Registrants Securities (Filed With SEC on March 23, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 23, 2022)
- Amendment to the Amended and Restated Employment Agreement, dated November 27, 2017, by and among Aptinyx, Inc. and Andrew D. Kidd (Filed With SEC on January 3, 2022)
- Amendment to the Amended and Restated Employment Agreement, dated August 29, 2015, by and among Aptinyx, Inc. and Norbert G. Riedel, Ph.D (Filed With SEC on January 3, 2022)
- Loan and Security Agreement, by and between Aptinyx Inc. and K2 HealthVentures LLC, dated September 15, 2021 (Filed With SEC on September 16, 2021)
- Sales Agreement, by and among Aptinyx Inc. and Cowen and Company, LLC, dated September 16, 2021 (Filed With SEC on September 16, 2021)
- Warrant to Purchase Shares of Common Stock by and between Aptinyx Inc. and K2 HealthVentures LLC, dated September 15, 2021 (Filed With SEC on September 16, 2021)
- Description of Registrants Securities (Filed With SEC on March 24, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on March 24, 2021)
- Underwriting Agreement, dated as of October 21, 2020, among Aptinyx Inc. and SVB Leerink LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co., as representatives of the... (Filed With SEC on October 22, 2020)
- Description of Registrants Securities (Filed With SEC on March 30, 2020)
- APTINYX INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 30, 2020)
- Underwriting Agreement, dated as of January 10, 2020, between Aptinyx Inc. and Cowen and Company, LLC, as representative of the underwriters named therein (Filed With SEC on January 13, 2020)
- Amended and Restated Investors' Rights Agreement among the Registrant and certain of its stockholders, dated December 11, 2017 (Filed With SEC on May 23, 2018)
- 2015 Stock Option and Grant Plan, amendments thereto, and forms of award agreements thereunder (Filed With SEC on May 23, 2018)
- Research Collaboration Agreement by and between Naurex Inc. (a wholly-owned subsidiary of Allergan plc) and the Registrant, dated as of July 24, 2015, as amended by Amendment No.... (Filed With SEC on May 23, 2018)
- Office Lease Agreement by and between FSP 909 Davis Street LLC and Registrant, dated as of October 13, 2016 (Filed With SEC on May 23, 2018)